39th International Congress of the ISBT (International Society of Blood Transfusion) 2026

The 39th International Congress of the ISBT (International Society of Blood Transfusion) 2026 addresses advances and practices in blood transfusion medicine, including donor management, blood products, transfusion safety, immunohematology, cellular therapies, and transfusion-transmitted infections.

Key Topics

• Blood donation
  Blood collection including apheresis, Blood donor recruitment, Rare donor programme and Donor adverse events
• Management and organisation
  Information technology, Organisational issues, Training and education, Cost/effectiveness, Blood supply management and utilization, Risk models, standards and regulation, Quality management and History
• Transfusion transmitted infections
  Hepatitis B (HBV), Screening strategies for TTI, HIV, Hepatitis C (HCV), Parasites, Bacteria, other transfusion related pathogens and Newly emerging pathogens and
• Blood products
  Blood components, Blood processing, storage and release, Pathogen inactivation, Plasma products, Novel blood products and Biologicals
• Clinical transfusion
  Therapeutic apheresis. Neonatal and pediatric transfusion, Haemorrhage and massive transfusion, Evidence based transfusion medicine practice, Haemovigilance and transfusion safety, Adverse events, including TRALI and Alternatives to blood transfusion
• Immune haematology
  Red cell immunology: Molecular, Red cell immunology: Serology, Granulocyte immunology, Platelet immunology, Diagnosis of TRALI and Fetal-maternal immunology
• Clinical immunogenetics
  Histocompatibility in stem cell transplantation, HLA in transfusion medicine and Histocompatibility in organ transplantation
• Cellular therapies
  Collection, processing, storage and release, Stem cell and tissue banking, including cord blood and Clinical applications
• Novel development